Northwestern Mutual Wealth Management Co. Sells 9,905 Shares of CVS Health Corporation $CVS

Northwestern Mutual Wealth Management Co. trimmed its holdings in shares of CVS Health Corporation (NYSE:CVS) by 7.6% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 120,524 shares of the pharmacy operator’s stock after selling 9,905 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in CVS Health were worth $12,468,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in shares of CVS Health during the second quarter worth $12,747,462,000. Norges Bank bought a new position in shares of CVS Health during the fourth quarter valued at approximately $1,666,265,000. Bank of America Corp DE increased its holdings in shares of CVS Health by 148.0% in the 2nd quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock valued at $2,398,868,000 after acquiring an additional 13,836,701 shares during the period. Wellington Management Group LLP raised its holdings in CVS Health by 193.2% in the fourth quarter. Wellington Management Group LLP now owns 18,564,392 shares of the pharmacy operator’s stock worth $1,473,270,000 after purchasing an additional 12,233,675 shares in the last quarter. Finally, Pzena Investment Management LLC acquired a new stake in CVS Health in the second quarter valued at approximately $1,217,558,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Price Performance

CVS Health stock opened at $97.20 on Thursday. The company has a fifty day simple moving average of $101.09 and a 200-day simple moving average of $89.96. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. The stock has a market cap of $124.31 billion, a P/E ratio of 25.71, a price-to-earnings-growth ratio of 0.95 and a beta of 0.59. CVS Health Corporation has a 12-month low of $69.51 and a 12-month high of $110.68.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. The firm had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The firm’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter last year, the business posted $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities analysts expect that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 2.7%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s dividend payout ratio is 70.37%.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on CVS shares. Royal Bank Of Canada increased their price target on CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Weiss Ratings upgraded CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, August 5th. DA Davidson raised their price objective on CVS Health from $80.00 to $100.00 and gave the company a “buy” rating in a report on Thursday, May 7th. Barclays lifted their price target on CVS Health from $106.00 to $108.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Finally, TD Cowen lifted their price target on shares of CVS Health from $105.00 to $110.00 and gave the company a “buy” rating in a research report on Monday, May 11th. Twenty-two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $107.17.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.